Health and Healthcare
La Jolla Pharmaceutical Shares Surge on Positive Trial Results
Published:
La Jolla Pharmaceutical Co. (NASDAQ: LJPC) shares surged after the micro-cap biotech said late Monday that its study for a chronic kidney disease treatment showed a statistically significant improvement.
The company said the randomized, placebo-controlled Phase II trial of GCS-100 in chronic kidney disease met its primary efficacy endpoint of a statistically significant improvement in kidney function. Key secondary endpoints were also met.
La Jolla Pharmaceutical CEO George Tidmarsh said:
We want to thank the patients who volunteered for this study and our excellent group of investigators for their hard work completing this Phase 2 trial in a timely fashion. We are obviously delighted with the results. … We hope to use these results as a platform for further investigation not only in chronic kidney disease but also in other diseases where tissue fibrosis plays a central role.
Chronic kidney disease reportedly affects 14% of Americans, or around 49 million people. GCS-100 is a high molecular weight, complex polysaccharide that inhibits galectin-3, a molecule suspected of playing a central role in tissue fibrosis. GCS-100 also has been shown to be therapeutically active in preclinical models of other diseases where tissue fibrosis plays a central role, such as nonalcoholic steatohepatitis.
La Jolla Pharmaceutical shares were up more than 58% in premarket trading to $17.27. The 52-week range had been $3.00 to $12.00.
Is Your Money Earning the Best Possible Rate? (Sponsor)
Let’s face it: If your money is just sitting in a checking account, you’re losing value every single day. With most checking accounts offering little to no interest, the cash you worked so hard to save is gradually being eroded by inflation.
However, by moving that money into a high-yield savings account, you can put your cash to work, growing steadily with little to no effort on your part. In just a few clicks, you can set up a high-yield savings account and start earning interest immediately.
There are plenty of reputable banks and online platforms that offer competitive rates, and many of them come with zero fees and no minimum balance requirements. Click here to see if you’re earning the best possible rate on your money!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
